ArticleBMC nephrology2026

Efficacy of immunosuppressive therapy in low-risk and intermediate- risk idiopathic membranous nephropathy patients : a 2-year follow-up study.

Yan Jin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.